Sign inJoin waitlistJoin the waitlist

Isabel Arrillaga-Romany

Physician · Massachusetts General Hospital

Credentials: · · · ·

History

Massachusetts General Hospital
Present

Neurology
Mass General Brigham
2008–2012
Tufts University School of Medicine
2004–2008

Research

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Nature Medicine · 2019 · 1,142 citations
Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells
Blood · 2019 · 291 citations
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
Nature Medicine · 2023 · 197 citations

PW
Patrick Wen
26 papers
Tracy Batchelor
22 papers
Jorg Dietrich
15 papers
Daniel Cahill
11 papers
David Reardon
11 papers
EG
Elizabeth Gerstner
11 papers
Eudocia Lee
11 papers
Deborah Forst
10 papers
Timothy Cloughesy
10 papers
Justin Jordan
9 papers
Julie Miller
8 papers
Lakshmi Nayak
8 papers

Clinical trials

Niraparib In Recurrent IDH 1/2 Gliomas
Principal investigator · Active not recruiting · Early phase 1
Massachusetts General Hospital
2023–2026
ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
Principal investigator · Recruiting · Phase 1
Massachusetts General Hospital
2019–2028
Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2017–2027
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
Site PI · Recruiting · Early phase 1
Ugonma Chukwueke
2025–2027